Therapy with bone marrow cells reduces liver alterations in mice chronically infected by Schistosoma mansoni

Figure 5 BMC therapy decreases the levels of TGF-β in the liver. TGF-β levels were assessed in fragments of hepatic tissue of uninfected, saline-treated or BMC-treated S. mansoni-infected mice 2 mo after BMC infusion by iv route, by sandwich ELISA. Data represents the mean ± SE of 4-8 animals per group. ^aP < 0.05 compared to uninfected group; ^bP < 0.01 compared to saline-treated group.